Artal Group’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-250,000
Closed -$9.29M 133
2020
Q3
$9.29M Buy
+250,000
New +$9.29M 0.23% 67